If Bill 53, introduced Tuesday afternoon by Dan Williams, Alberta’s minister of mental health and addictions, becomes law, it ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Alberta is taking another bold step in the fight against opioids and addictions, one that could save lives, but also one that ...

NEW YORK (AP) — The latest government waste touted by billionaire Elon Musk’s cost-cutting Department of Government ...

A growing number of millennials and Gen Zers are turning to the right in their bid for a better future. Here, five first-time ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

University of California, Davis, researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that ...

President Donald Trump’s promise to impose tariffs on pharmaceutical imports is raising red flags among generic drugmakers and industry experts, who warn that such a move could lead to increased drug ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...

Insurance companies face a growing challenge as they adapt to the rise of GLP-1 receptor agonists, such as Ozempic and Wegovy ...

I believe AI offers a path to not just patch the system but to reimagine it entirely. Where It Breaks Down. Prior authori ...

The president aims to "reevaluate the role of the intermediary" in the pharmaceutical value chain. U.S. President Donald Trump has signed an executive order aimed at reducing drug prices, accelerating ...